Related Experiment Video

Updated: Aug 7, 2026

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
07:55

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

Altered beta-amyloid precursor protein isoforms in Mexican Alzheimer's Disease patients

V J Sánchez-González1, G G Ortiz, P Gallegos-Arreola

  • 1Laboratorio de Desarrollo-Envejecimiento, Enfermedades Neurodegenerativas, División de Neurociencias, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, México. vjzahiiir@yahoo.com

Disease Markers
|June 22, 2006
PubMed
Abstract

Insights

A lower beta-amyloid precursor protein (betaAPP) ratio is a significant risk factor for Alzheimer's Disease (AD). This altered betaAPP ratio does not influence the disease's onset timing.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Alzheimer's Disease (AD) is a progressive neurodegenerative disorder.
  • Beta-amyloid precursor protein (betaAPP) plays a critical role in AD pathogenesis.
  • Understanding betaAPP isoforms and their ratios may offer insights into AD risk.

Purpose of the Study:

  • To investigate the ratio of betaAPP isoforms as a potential risk factor for Alzheimer's Disease.
  • To examine the association between the betaAPP isoforms ratio and demographic/genetic factors in AD.

Main Methods:

  • Western blotting was used to analyze betaAPP isoforms in blood samples from AD patients and healthy controls.
  • A ratio of betaAPP isoforms was calculated based on optical densities of specific bands.
  • Odds ratios were computed to assess the risk associated with the betaAPP ratio.

Main Results:

  • The betaAPP ratio was significantly lower in AD subjects compared to controls (0.3662 vs. 0.6769, p<0.05).
  • A low betaAPP ratio (<0.6) indicated an increased risk for AD, with an Odds Ratio of 4.63.
  • No significant difference in betaAPP ratio was observed between early-onset AD (EOAD) and late-onset AD (LOAD) subjects.

Conclusions:

  • Altered betaAPP isoforms represent a substantial risk factor for developing Alzheimer's Disease.
  • The betaAPP isoforms ratio does not appear to influence the age of disease onset.

More Related Videos

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by &#947;-Secretase11:57

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase

Published on: June 24, 2025

Visualization of Amyloid &#946; Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry09:31

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...